Ependymoma.
BACKGROUND
The management of a patient with an ependymoma is controversial. Although the necessity for a multi-disciplined approach is accepted, the exact roles for all disciplines are poorly defined.


METHODS
This review article examines the current status of histopathological and cytogenetic diagnosis, surgical, chemotherapeutic and radiotherapeutic treatment and future directions.
Teo
Charles
C
Department of Neurosurgery, Sydney Children's Hospital, Randwick, NSW 2031, Australia. charlie@neuroendoscopy.info
Nakaji
Peter
P
Symons
Patricia
P
Tobias
Vivienne
V
Cohn
Richard
R
Smee
Robert
R
D001932:Brain Neoplasms / Q000145:classification / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D002648:Child; D002892:Chromosomes, Human, Pair 22 / Q000235:genetics; D003388:Cranial Fossa, Posterior / Q000473:pathology*; D003582:Cytogenetics / Q000379:methods; D004806:Ependymoma / Q000145:classification / Q000235:genetics / Q000473:pathology* / Q000628:therapy; D016515:Genes, Neurofibromatosis 2; D016158:Genes, p53 / Q000235:genetics; D006801:Humans; D019635:Neurosurgical Procedures / Q000379:methods; D017354:Point Mutation / Q000235:genetics